← Back to Search

Educational Videos for Cancer Communication

N/A
Recruiting
Led By Rebecca Pentz, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 years
Awards & highlights

Summary

This trial looks at how patients & providers communicate about immunotherapy & how educational videos can improve patient understanding.

Who is the study for?
This trial is for patients and healthcare providers at the Winship Cancer Institute who may discuss immunotherapy. It's also open to any cancer patient interested in how educational videos can help understand immunotherapy.Check my eligibility
What is being tested?
The study looks at communication issues during discussions about immunotherapy between patients and providers. It aims to find out where patients learn about it, their understanding, how healthcare workers explain it, and if videos improve patient knowledge.See study design
What are the potential side effects?
Since this trial involves educational materials like videos and interviews rather than medical treatments, there are no direct physical side effects associated with participating.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correct definition rates (pre- versus post-video)
Misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources
Provider and patient preferences for information to be communicated about immunotherapy
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: InterviewExperimental Treatment2 Interventions
Patients and providers undergo observation during a conversation about immunotherapy. Then participate in an interview over 20 minutes.
Group II: Aim 4 tests an educational videoExperimental Treatment1 Intervention
The participants watch a video and their comprehension is tested in a pre and post methodology

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,655 Previous Clinical Trials
2,572,358 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,748 Previous Clinical Trials
40,959,276 Total Patients Enrolled
2 Trials studying Blood Cancers
110 Patients Enrolled for Blood Cancers
Rebecca Pentz, PhDPrincipal InvestigatorEmory University Hospital/Winship Cancer Institute
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Interview Clinical Trial Eligibility Overview. Trial Name: NCT05873608 — N/A
Blood Cancers Research Study Groups: Interview, Aim 4 tests an educational video
Blood Cancers Clinical Trial 2023: Interview Highlights & Side Effects. Trial Name: NCT05873608 — N/A
Interview 2023 Treatment Timeline for Medical Study. Trial Name: NCT05873608 — N/A
~12 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top